Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
5.00    -0.10 (-1.96%)
Bid:
5.00
Ask:
5.10
Spread: 0.10 (2.00%)
Market Cap: £43.49m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Grant of Share Options

16 Apr 2026 07:00

RNS Number : 6493A
Revolution Beauty Group PLC
16 April 2026
 

16 April 2026

Revolution Beauty Group plc

("Revolution Beauty" or the "Company")

Grant of Share Options

Revolution Beauty (AIM: REVB), the multi-channel mass beauty brand, announces the grant of 44,800,000 share options (the "Options") over ordinary shares of 0.1 pence each ("Ordinary Shares") to two Directors and a number of employees and consultants of the Company, under the Revolution Beauty Long Term Incentive Plan ("LTIP"). The Options, representing 5.2 per cent. of the Company's existing issued share capital, have an exercise price of 3 pence per Ordinary Share. The closing mid-market price of an Ordinary Share on 15 April 2026, the date of the grant, was 3.1 pence. All of the Options will vest in three equal tranches on the following vesting dates: 25 November 2026, 25 November 2027 and 25 November 2028.

Of the 44,800,000 Options granted, 3,500,000 Options have been granted to Tom Allsworth (Co-founder and CEO) and 3,500,000 to Neil Catto (CFO) as follows:

Director

Existing options over Ordinary Shares held

Number of Options granted

Total options held following grant

% of current issued share capital

Tom Allsworth

-

3,500,000

3,500,000

0.40%

Neil Catto

3,000,000

3,500,000

6,500,000

0.75%

In addition, 3,500,000 Options have been granted to Adam Minto as co-founder of the business.

 

Of the total 44,800,000 Options granted, 11,500,000 Options are non-tax advantaged share options over Ordinary Shares to employees or consultants of the Company who are either not resident in the UK or not eligible for Enterprise Management Incentive ("EMI") qualifying options. The remaining 33,300,000 Options are EMI qualifying options. Following the grant of the Options, the Company has options outstanding over a total of 53,724,606 Ordinary Shares, representing 6.2% of the Company's current issued share capital. The Company has consulted with major shareholders regarding the grant of the Share Options.

The FCA notifications, made in accordance with the requirements of the UK Market Abuse Regulation are appended further below.

 

Investor Relations

Tom Allsworth, CEO

Neil Catto, CFO

Investor.Relations@revolutionbeautyplc.com

 

 

Strand Hanson Limited (Nominated Adviser)

Christopher Raggett / Carl Holmes / Imogen Ellis

Tel: +44 (0)20 7409 3494

 

 

Zeus Capital (Broker)

Ben Robertson / Dominic King / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

 

Headland Consultancy (Media Enquiries)

Matt Denham / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Tom Allsworth

2

Reason for the notification

a)

Position/status

Co-founder and CEO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Revolution Beauty Group plc

b)

LEI

21380083TTJWXK677H17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of £0.01 each in the capital of the Company

 

ISIN: GB00BP7L1T61

b)

Nature of the transaction

Grant of options under the Revolution Beauty LTIP

c)

Price(s) and volume(s)

Prices

Exercise price £0.03

Volume(s)

3,500,000

d)

Aggregated information

Single transaction as in 4 c) above

e)

Date of the transaction

15 April 2026

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Neil Catto

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Revolution Beauty Group plc

b)

LEI

21380083TTJWXK677H17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of £0.01 each in the capital of the Company

 

ISIN: GB00BP7L1T61

b)

Nature of the transaction

Grant of options under the Revolution Beauty LTIP

c)

Price(s) and volume(s)

Prices

Exercise price £0.03

Volume(s)

3,500,000

d)

Aggregated information

Single transaction as in 4 c) above

e)

Date of the transaction

15 April 2026

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKPBPABKDPQD
Date   Source Headline
8th Jun 20267:00 amRNSNew Licensing Partnership with Debenhams Group
5th Jun 20267:00 amRNSFinancial Conduct Authority Update
16th Apr 20267:00 amRNSGrant of Share Options
1st Apr 202611:35 amRNSTotal Voting Rights
11th Mar 20267:00 amRNSAppointment of Nominated Adviser
2nd Mar 202611:28 amRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20263:48 pmRNSTotal Voting Rights
15th Dec 20256:18 pmRNSDirector/PDMR Shareholding
1st Dec 20255:43 pmRNSTotal Voting Rights
27th Nov 20253:59 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSInterim Results
26th Nov 20256:15 pmRNSRelated Party Transaction
4th Nov 20254:32 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20259:33 amRNSResult of AGM
24th Sep 20257:00 amRNSDirectorate Change
18th Sep 20257:00 amRNSHolding(s) in Company
17th Sep 202512:30 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSDirector/PDMR Shareholding
16th Sep 20255:17 pmRNSHolding(s) in Company
16th Sep 20259:11 amRNSHolding(s) in Company
11th Sep 20254:09 pmRNSResults of General Meeting
2nd Sep 20258:30 amRNSTotal Voting Rights
1st Sep 20255:06 pmRNSHolding(s) in Company
1st Sep 20258:33 amRNSHolding(s) in Company
29th Aug 20254:50 pmRNSFinal Results, Annual Report Posting & AGM Notice
26th Aug 20257:01 amRNSCircular Publication, Notice of GM & Board Update
26th Aug 20257:00 amRNSResult of Retail Offer to existing shareholders
22nd Aug 20254:31 pmRNSPDMR Dealing
22nd Aug 20253:30 pmRNSHolding(s) in Company
22nd Aug 20258:52 amRNSHolding(s) in Company
22nd Aug 20258:40 amRNSRetail Offer to existing shareholders
22nd Aug 20258:09 amRNSResult of Placing and Subscription
22nd Aug 20257:02 amRNSProposed Placing and Subscription via ABB
22nd Aug 20257:01 amRNSPreliminary Unaudited Results
22nd Aug 20257:00 amRNSTermination of Formal Sale Process
21st Aug 202510:51 amRNSForm 8.5 (EPT/RI)
20th Aug 202510:28 amRNSForm 8.5 (EPT/RI)
19th Aug 202512:27 pmRNSFY25 Trading Update
19th Aug 202510:01 amRNSForm 8.5 (EPT/RI)
18th Aug 202510:27 amRNSForm 8.5 (EPT/RI)
15th Aug 20254:11 pmRNSHolding(s) in Company
15th Aug 20259:57 amRNSForm 8.5 (EPT/RI)
14th Aug 202510:25 amRNSForm 8.5 (EPT/RI)
13th Aug 202510:31 amRNSForm 8.5 (EPT/RI)
12th Aug 202510:05 amRNSForm 8.5 (EPT/RI)
11th Aug 202510:26 amRNSForm 8.5 (EPT/RI)
8th Aug 202511:31 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.